About myBioma
"We're taking a close look at the gut microbiome!"
Clearly defined
Our vision
The vision of myBioma is to improve the gut health of every person and thereby enhance their quality of life. At myBioma, we understand that health starts in the gut. However, to address this, one must first know what is happening inside. Since 2018, we have been supporting our customers with our gut microbiome analysis. To do this, we use the latest scientific findings and technological methods.
Simultaneously, we are actively working to harness the diverse diagnostic potential of the gut microbiome. Currently, we are involved in several clinical studies to evaluate the significance of the gut microbiome for medical therapies. In the future, diagnoses and specific treatment plans should be based on the individual gut microbiome of patients(see BiomeDx).
-
Alexander Knabl, PhD
Head of Business Development
-
Anni Grimm
Marketing Manager
-
Armin Stahlberg
Logistics
-
Cátia Pacífico, PhD
Senior Scientist
-
Christoph Alge
Frontend Developer
-
Deniz Inan, MSc
Business Developer
-
Eva Anna
Quality Manager
-
Evelyn Weiler
Community Manager
-
Felix Müllner
Backend Developer
-
Georg Scharinger, MSc
Lead Developer
-
Harry Purewal
Performance Marketing
-
Marjan Kusebauch
Designer
-
Michelle Kornherr
Logistics
-
Rafaella Shinmyo, MSc
Content Manager
-
Renate Matzner, MSc
Partner Manager
-
Univ.-Prof.in Dr.in Christine Moissl-Eichinger
Advisor
-
Univ.-Prof. David Berry, PhD
Advisor
-
Univ.-Prof. Dipl.-Biol. Dr. Alexander Loy
Advisor
Our reliable
Partner laboratory
We have a long-standing research collaboration with our partner laboratory at the Medical University of Vienna. The Next-Generation DNA Sequencing laboratory method is used for the myBioma gut microbiome analysis. This allows for the determination of the genetic information of each bacterium in a stool sample.
Our ongoing
Research on the microbiome
Research is where innovation meets discovery! At myBioma, it's crucial for us to always stay at the cutting edge of knowledge. That is why we are actively involved in research projects.
-
Irritable bowel and microbiome
We investigate the microbial signature of irritable bowel syndrome (IBS) using biofilms. At the same time, we analyse the impact of endoscopic biofilm removal on the restoration of a "healthy" microbiome composition and bile acid metabolism.
-
Colorectal cancer and microbiome
We define predictive microbiome-based signatures that are specific to colorectal cancer and high-risk adenomas, using multivariate statistical modeling.
-
Acne and the microbiome
This interventional, double-blind, placebo-controlled clinical trial will investigate the connections between acne/rosacea and the gut microbiome during oral probiotic therapy.
